Our Journey

The journey continues with 4300 global individuals in 31 countries spreading our commitment of “We care”.

Passion, Machines & Soft gelatine capsules – This is the story we tell to our customers, our staff and our partners. The birth of Mega lifesciences, a maverick organization founded on simple universal values, started its journey in 1982 with a drive to keep human’s stay healthy. From two machines and few people to four world class factories in Thailand and Australia is a big journey in itself in the last three decades.

Travel with us on our journey, experience our continuous evolvement to keep pace with the needs and expectations of our customers, employees and stakeholders.

1982-1991
  • 1982

    Mr. Kirit Shah & Mr. Vikram Tannan incorporated “Vikas Company Limited” which was reformed to “Medicap Limited” post BOI approval to set up softgel facility at SAMUTPARKARN

  • 1985

    “Soi 6, Samut Prakran, Thailand” Our first manufacturing facility with 2 machines received a license from Thai FDA to produce medicines with annual capacity of 230 million

    Began manufacturing Nifedipine for Berlin Pharmaceutical Industry Co., Ltd

  • 1986

    Mr D.N.Azad joins at CEO & Mr.Vivek Dhawan now the Company’s Chief Executive Officer, joined as Plant Manager with a team of 10 people.

  • 1988-1989

    Added 2 more production lines to our manufacturing capacity, after receving 2nd BOI approval to increase capacity.

    Increased our annual production capacity to 625 million soft gel capsules by adding 5th machine to our facility. Received Food license from TFDA

  • 1990

    “Mega Products Limited” was formed to market and sell nutraceutical products under our own brands.

1992-2001
  • 1993

    Therapeutic Goods Administration (TGA) Australia audits manufacturing facility at Mega.

  • 1994

    Acquired the MedicraftsTM brand and associated trademarks for a range of products; it helped in growing our branded products and its market acceptance.

    Soi 6 manufacturing facility received GMP certification from the Australian TGA.

  • 1995-1996

    Established operations in Myanmar (’95), Vietnam (’95) and Cambodia (’96) to market and sell our own brands and developed our distribution business as well.

    Added 3 more machines to our capacity.

  • 1997

    We become the first pharmaceutical company in Thailand to receive the ISO 9002 certification.

  • 2000

    Launched our own brands into developing markets including the Commonwealth of Independent States and countries in Africa and the Middle East(Kenya, Tanzania and Uganda).

  • 2001

    Mega We careTM registered as trademark.

    Our manufacturing facility in Soi 6 obtained GMP certification from the German health authority, the district government of Arnsberg.

    First Thai pharmaceutical company to export nutraceutical and pharmaceutical products to Germany Initiate Brand business in Yemen & Malaysia.

2002-2011
  • 2002

    Started manufacturing facility in Dandenong, Melbourne, Australia and received a TGA licence for the operations.

    Initiate Brand business in Nigeria & Ukraine.

  • 2003

    Initiate Brand business in ,Kazakhstan,Azerbaijan and Singapore.

  • 2004

    Our Soi 6 manufacturing facility received GMP certificate from Uganda, Nigeria, Tanzania and Danish health authorities.

  • 2005

    Changed our company name from “Medicap Limited” to “Mega Lifesciences Company Limited”.

  • 2006

    Ministry of Health of Yemen and Ukraine awarded the GMP certification to our Soi 6 manufacturing facility in Thailand.

    Mega Lifesciences Company Limited, Myanmar became the first distribution and logistics company in Myanmar to receive ISO 9001 certification.

  • 2008

    Our 2nd manufacturing facility was established in Soi 8 in samut prakran, Thailand for manufacturing tablets, hard capsules and packages commencing next year.

    GMP certifications for our Soi 6, Thailand and Australian manufacturing facilities from United Arab Emirates ministry of health.

    Initiate Brand business in Uzbekistan and Ghana.

  • 2009

    We received GMP certification for our Soi 6 manufacturing facility from the Oman Ministry of Health.

    In the same year, we received GMP certification for our Soi 8 manufacturing facility from: (i) the District Government of Arnsberg in Germany; (ii) the Thai FDA; and (iii) the Australian TGA.

    Initiate Brand business in Peru.

  • 2010

    We registered “Maxxcare” as a trademark in 2010. MaxxcareTM is the primary trademark for our distribution business.

    GMP certifications for our Soi 8 manufacturing facility from the Ukrainian Ministry of Health.

    Both of our manufacturing facilities in Thailand also received certification from the Ethiopian Drug and Administration Authority

    Replaced existing eight production lines and added two more production lines to our first manufacturing facility in Samut Prakarn, Thailand. Annual capacity increased to 2.1 billion.

2012-2016
  • 2012

    GMP certification for our Soi 6 manufacturing facility from the Ministry of Health of Sudan.

    Our Soi 8 manufacturing facility in Thailand received GMP certification from the Ministry of Health of Yemen.

    In addition, both of our manufacturing facilities in Thailand received GMP certification from the Ministry of Health of Peru.

    • We received the Taxpayers’ Recognition Award 2011, an award recognizing taxpayer responsibility, from the Thai Revenue Department in recognition of our being a good corporate citizen with good corporate governance and best practices in paying taxes.
    • Acquired the EugicaTM brand, intellectual property and title documents.
    • According to IMS Health data as of June 2013, a number of our branded products were ranked number one in their respective market categories in 2012.
    • Commenced work on extension of the second facility to include new PD lab ,manufacturing and packing area.Commenced work on new manufacturing facility in Australia.

  • 2013

    We received GMP certifications from the Ugandan National Drug Authority and the United Arab Emirates’ Ministry of Health for our Soi 8 manufacturing facility in Thailand.

    We relocated our manufacturing facility in Australia from Dandenong to a newly constructed manufacturing facility in Pakenham, Melbourne (“Pakenham Facility”), also received GMP certification from the Australian TGA.

    • Production capacity at Australia to increase to 250 million tablets,30 million hardgel and 800 metric tonnes of powder handling capacity per annum. For Tablets, hard gel, capsule & powder.
    • 4000 members make up the global mega family.
    • Transformed our Company into a public company, we got listed in Thailand Stock exchange in November 2013 and changed our name to Mega Lifesciences Public Company Limited.

  • 2016

    The journey of expansion to human wellness continues.

Find out more

Our Leadership

Meet our board of directors who carries the main responsibility...

Know More

Mega Journey

Passion, Machines & Soft gelatine capsules – This is the story we tell to...

Know More